• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APP/PS1KI小鼠模型综述:神经元内β淀粉样蛋白聚集引发轴突病变、神经元丢失和工作记忆损害。

Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.

作者信息

Bayer T A, Wirths O

机构信息

Division of Molecular Psychiatry, Department of Psychiatry, University of Goettingen, Goettingen, Germany.

出版信息

Genes Brain Behav. 2008 Feb;7 Suppl 1:6-11. doi: 10.1111/j.1601-183X.2007.00372.x.

DOI:10.1111/j.1601-183X.2007.00372.x
PMID:18184366
Abstract

Accumulating evidence points to an important role of intraneuronal Abeta as a trigger of the pathological cascade of events leading to neurodegeneration and eventually to Alzheimer's disease (AD) with its typical clinical symptoms, like memory impairment and change in personality. As a new concept, intraneuronal accumulation of Abeta instead of extracellular Abeta deposition has been introduced to be the disease-triggering event in AD. The present review compiles current knowledge on the amyloid precursor protein (APP)/PS1KI mouse model with early and massive intraneuronal Abeta42 accumulation: (1) The APP/PS1KI mouse model exhibits early robust brain and spinal cord axonal degeneration and hippocampal CA1 neuron loss. (2) At the same time-point, a dramatic, age-dependent reduced ability to perform working memory and motor tasks is observed. (3) The APP/PS1KI mice are smaller and show development of a thoracolumbar kyphosis, together with an incremental loss of body weight. (4) Onset of the observed behavioral alterations correlates well with robust axonal degeneration in brain and spinal cord and with abundant hippocampal CA1 neuron loss.

摘要

越来越多的证据表明,神经元内β淀粉样蛋白(Aβ)作为导致神经退行性变并最终发展为具有典型临床症状(如记忆障碍和人格改变)的阿尔茨海默病(AD)的病理事件级联反应的触发因素,起着重要作用。作为一个新概念,Aβ在神经元内的积累而非细胞外Aβ沉积已被认为是AD中引发疾病的事件。本综述汇集了关于淀粉样前体蛋白(APP)/早老素1基因敲入(PS1KI)小鼠模型的现有知识,该模型中神经元内早期大量积累Aβ42:(1)APP/PS1KI小鼠模型表现出早期强烈的脑和脊髓轴突变性以及海马CA1神经元丢失。(2)在同一时间点,观察到执行工作记忆和运动任务的能力显著下降,且与年龄相关。(3)APP/PS1KI小鼠体型较小,出现胸腰椎后凸,体重逐渐减轻。(4)观察到的行为改变的起始与脑和脊髓中强烈的轴突变性以及大量海马CA1神经元丢失密切相关。

相似文献

1
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.APP/PS1KI小鼠模型综述:神经元内β淀粉样蛋白聚集引发轴突病变、神经元丢失和工作记忆损害。
Genes Brain Behav. 2008 Feb;7 Suppl 1:6-11. doi: 10.1111/j.1601-183X.2007.00372.x.
2
Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease.阿尔茨海默病APP/PS1基因敲入小鼠模型的工作记忆和运动能力缺陷
Neurobiol Aging. 2008 Jun;29(6):891-901. doi: 10.1016/j.neurobiolaging.2006.12.004. Epub 2007 Jan 9.
3
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.神经元内β-淀粉样蛋白是一个主要风险因素——来自APP/PS1KI小鼠模型的新证据。
Neurodegener Dis. 2008;5(3-4):140-2. doi: 10.1159/000113684. Epub 2008 Mar 6.
4
Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.在APP/PS1KI小鼠的额叶皮质中,短暂的神经元内β淀粉样蛋白而非细胞外斑块病理与神经元丢失相关。
Acta Neuropathol. 2008 Dec;116(6):647-55. doi: 10.1007/s00401-008-0451-6. Epub 2008 Oct 31.
5
APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.APP/PS1KI双转基因小鼠出现早期突触缺陷和海马萎缩。
Acta Neuropathol. 2009 Jun;117(6):677-85. doi: 10.1007/s00401-009-0539-7. Epub 2009 Apr 23.
6
Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.在阿尔茨海默病的 APP/PS1KI 小鼠模型的大脑和脊髓中,炎症变化与神经退行性变密切相关。
Neurobiol Aging. 2010 May;31(5):747-57. doi: 10.1016/j.neurobiolaging.2008.06.011. Epub 2008 Jul 26.
7
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.阿尔茨海默病APP/PS1转基因小鼠模型中的轴突病
Acta Neuropathol. 2006 Apr;111(4):312-9. doi: 10.1007/s00401-006-0041-4. Epub 2006 Mar 7.
8
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.阿尔茨海默病 5XFAD 小鼠模型中轴突变性和神经元内 Aβ 聚集伴随运动缺陷、神经元丢失和焦虑减轻。
Neurobiol Aging. 2012 Jan;33(1):196.e29-40. doi: 10.1016/j.neurobiolaging.2010.05.027. Epub 2010 Jul 9.
9
Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.细胞内 Aβ 触发阿尔茨海默病 APP/PS1KI 小鼠模型胆碱能系统神经元丢失。
Neurobiol Aging. 2010 Jul;31(7):1153-63. doi: 10.1016/j.neurobiolaging.2008.07.022. Epub 2008 Sep 3.
10
Age-dependent axonal degeneration in an Alzheimer mouse model.阿尔茨海默病小鼠模型中与年龄相关的轴突变性
Neurobiol Aging. 2007 Nov;28(11):1689-99. doi: 10.1016/j.neurobiolaging.2006.07.021. Epub 2006 Sep 11.

引用本文的文献

1
Identification of TMED10 as A Regulator for Neuronal Exocytosis of Amyloid Beta 42.鉴定TMED10作为淀粉样β蛋白42神经元胞吐作用的调节因子。
Neurosci Bull. 2025 Sep 5. doi: 10.1007/s12264-025-01492-3.
2
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
3
Amyloid precursor protein and presenilin-1 knock-in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss.
淀粉样前体蛋白和早老素-1基因敲入免疫缺陷小鼠表现出神经元内β淀粉样蛋白病理改变、小胶质细胞增生以及广泛的神经元丢失。
Alzheimers Dement. 2025 Apr;21(4):e70084. doi: 10.1002/alz.70084.
4
Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.在阿尔茨海默病受累神经元中,淀粉样前体蛋白水解途径中β淀粉样蛋白的产生停止或受到严重抑制:对“显而易见”的观点提出质疑。
Genes (Basel). 2025 Jan 2;16(1):46. doi: 10.3390/genes16010046.
5
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.精髓协同作用:同时给予综合应激反应抑制剂和 BACE1 和/或 BACE2 激活剂,作为阿尔茨海默病的最佳治疗策略。
Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913.
6
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.
7
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.论当前阿尔茨海默病转基因动物模型的不足:未来之路
Int J Mol Sci. 2024 Mar 4;25(5):2981. doi: 10.3390/ijms25052981.
8
Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (Aβ) by Its Targeted Degradation via Augmentation of Intra-Aβ-Cleaving Activities of BACE1 and/or BACE2.用于治疗和预防阿尔茨海默病和与衰老相关的认知能力下降的下一代治疗策略:通过增强 BACE1 和/或 BACE2 的 intra-Aβ 裂解活性,靶向性地使细胞内 Aβ (Aβ) 短暂、一次性耗尽。
Int J Mol Sci. 2023 Dec 18;24(24):17586. doi: 10.3390/ijms242417586.
9
Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer's Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions.ACH2.0视角下阿尔茨海默病及衰老相关认知衰退防治临床试验的设计原则:潜在结果、挑战与解决方案
J Alzheimers Dis Rep. 2023 Aug 28;7(1):921-955. doi: 10.3233/ADR-230037. eCollection 2023.
10
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.阿尔茨海默病和与衰老相关的认知能力下降的淀粉样蛋白级联假说 2.0:从分子基础到有效治疗。
Int J Mol Sci. 2023 Jul 31;24(15):12246. doi: 10.3390/ijms241512246.